The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter

This publication has 35 references indexed in Scilit:

• Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
  Published by Elsevier ,2004
• Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
  Published by Elsevier ,2002
• Differences in the reserpine-sensitive storage in vivo of 1-methyl-4-phenylpyridinium in rats and mice may explain differences in catecholamine toxicity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  Neurotoxicology and Teratology, 1994
• Extensive sequence divergence between the human and rat brain vesicular monoamine transporter: Possible molecular basis for species differences in the susceptibility to MPP+
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
• A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter
  Cell, 1992
• Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+
  Neuroscience Letters, 1987
• II. Selective accumulation of MPP+ in the substantia nigra: A key to neurotoxicity?
  Life Sciences, 1985
• Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
  Nature, 1984
• Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice
  Science, 1984
• Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
  Science, 1983